Survival was longer in patients who received radium-223 plus abiraterone, enzalutamide, or both.
Read the source article at Renal & Urology News
Categories: Market Trends
Survival was longer in patients who received radium-223 plus abiraterone, enzalutamide, or both.
Read the source article at Renal & Urology News
Categories: Market Trends